<?xml version="1.0" encoding="UTF-8"?>
<p>During their conduct, all trials have regularly exchanged information with their local and/or national health authorities, especially to communicate the trial progresses and the variety of sources of uncertainties that could influence their outputs. This review is an opportunity to provide policy makers with a comprehensive overview of the characteristics of all trials, which are likely to affect the results of the implemented UTT strategies in different contexts. All trials have efficiently adapted their design and interventions to changing guidelines both for ethical reasons and to ensure that their results are of maximal relevance to the public health landscape. Collectively, the trials represent the most relevant information to help answer policy and resource allocation questions. While the plea for UTT is now clear, many countries still need to evaluate the feasibility and cost of adopting such a strategy into their national health system 
 <xref rid="jia225048-bib-0013" ref-type="ref">13</xref>. A clear understanding of the available evidence will be a key for informed policy formulation.
</p>
